Treatment of prostate cancer in unfit senior adult patients

Cristina Falci; Elisabetta Morello; Jean Pierre Droz

doi:10.1016/j.ctrv.2009.04.014

Treatment of prostate cancer in unfit senior adult patients

Cristina Falci, Elisabetta Morello, Jean Pierre Droz

Istituto Oncologico Veneto

Research output: Contribution to journal › Article › peer-review

Abstract

Prostate cancer is a disease typical of the elderly with a peak of incidence at 80 years. As most patients aged ≥70 years show impairment of physical and/or cognitive performance, a complete geriatric assessment should be mandatory before planning any oncological treatment, in order to remove treatable conditions and to estimate the individual cancer-independent survival probability. In unfit patients with early prostate cancer watchful waiting represent the best strategy when the chance of living

Original language	English
Pages (from-to)	522-527
Number of pages	6
Journal	Cancer Treatment Reviews
Volume	35
Issue number	6
DOIs	https://doi.org/10.1016/j.ctrv.2009.04.014
Publication status	Published - Oct 2009

Keywords

Chemotherapy
Elderly
Geriatric assessment
Hormonal therapy
Prostate cancer
Radiotherapy
Unfit

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.ctrv.2009.04.014

Fingerprint Dive into the research topics of 'Treatment of prostate cancer in unfit senior adult patients'. Together they form a unique fingerprint.

Cite this

@article{1140ee0104644a2cafc53c4b156df4d4,

title = "Treatment of prostate cancer in unfit senior adult patients",

abstract = "Prostate cancer is a disease typical of the elderly with a peak of incidence at 80 years. As most patients aged ≥70 years show impairment of physical and/or cognitive performance, a complete geriatric assessment should be mandatory before planning any oncological treatment, in order to remove treatable conditions and to estimate the individual cancer-independent survival probability. In unfit patients with early prostate cancer watchful waiting represent the best strategy when the chance of living ",

keywords = "Chemotherapy, Elderly, Geriatric assessment, Hormonal therapy, Prostate cancer, Radiotherapy, Unfit",

author = "Cristina Falci and Elisabetta Morello and Droz, {Jean Pierre}",

year = "2009",

month = oct,

doi = "10.1016/j.ctrv.2009.04.014",

language = "English",

volume = "35",

pages = "522--527",

journal = "Cancer Treatment Reviews",

issn = "0305-7372",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Treatment of prostate cancer in unfit senior adult patients

AU - Falci, Cristina

AU - Morello, Elisabetta

AU - Droz, Jean Pierre

PY - 2009/10

Y1 - 2009/10

N2 - Prostate cancer is a disease typical of the elderly with a peak of incidence at 80 years. As most patients aged ≥70 years show impairment of physical and/or cognitive performance, a complete geriatric assessment should be mandatory before planning any oncological treatment, in order to remove treatable conditions and to estimate the individual cancer-independent survival probability. In unfit patients with early prostate cancer watchful waiting represent the best strategy when the chance of living

AB - Prostate cancer is a disease typical of the elderly with a peak of incidence at 80 years. As most patients aged ≥70 years show impairment of physical and/or cognitive performance, a complete geriatric assessment should be mandatory before planning any oncological treatment, in order to remove treatable conditions and to estimate the individual cancer-independent survival probability. In unfit patients with early prostate cancer watchful waiting represent the best strategy when the chance of living

KW - Chemotherapy

KW - Elderly

KW - Geriatric assessment

KW - Hormonal therapy

KW - Prostate cancer

KW - Radiotherapy

KW - Unfit

UR - http://www.scopus.com/inward/record.url?scp=70349319631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349319631&partnerID=8YFLogxK

U2 - 10.1016/j.ctrv.2009.04.014

DO - 10.1016/j.ctrv.2009.04.014

M3 - Article

C2 - 19487081

AN - SCOPUS:70349319631

VL - 35

SP - 522

EP - 527

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - 6

ER -